Back to TMO
Candriam S.C.A. TMO Position History
Thermo Fisher Scientific Inc. • Healthcare
Quarters held
6
Latest value
$274.1M
Q3 2026
Peak value
$274.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $132M |
| Q4 2025 | $172.5M |
| Q4 2025 | $172.5M |
| Q1 2026 | $174M |
| Q2 2026 | $174M |
| Q3 2026 | $274.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $274.1M | 404.5K | — | — |
| Q2 2026 | $174M | 347.4K | — | — |
| Q1 2026 | $174M | 354.1K | — | — |
| Q4 2025 | $172.5M | 297.7K | — | — |
| Q4 2025 | $172.5M | 297.7K | — | — |
| Q3 2025 | $132M | 272.1K | — | — |
Other funds holding TMO
$17.6B
$15.8B
$14.7B
$10.1B
$9.6B
$9.6B